The report will be delivered in 2-3 business days.

Viral Vectors & Plasmid DNA Market Global Report 2020-30: Covid 19 Implications And Growth

Starting Price : $ 4000.00 $3200.00 | Pages : 150 | Published : July 2020 | SKU CODE : 7569 | Format :


The viral vectors & plasmid DNA market consists of sales of viral vectors & plasmid DNA and related services. The viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. The viral vectors & plasmid DNA are used for formulation development in research and development labs. The viral vectors are genetically engineered viruses carrying viral RNA or DNA that is noninfectious but still contain viral promoters and transgene. The plasmid DNA is a double-stranded extrachromosomal and circular DNA sequence that is capable of replication using the host cell`s replication system.

The global viral vectors & plasmid DNA market is expected to grow from $0.46 billion in 2019 to $0.60 billion in 2020 at a compound annual growth rate (CAGR) of 31.3%. The growth is mainly due to the outbreak of COVID 19 and requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing resulting in a surge in demand for viral vectors & plasmid DNA. The market is expected to reach $1.05 billion in 2023 at a CAGR of 20.4%.

North America was the largest region in the viral vectors and plasmid DNA market in 2019. Asia Pacific is expected to be the fastest-growing region in the forecast period.

The rise in the global incidence of cancer is driving the viral vector & plasmid DNA market. According to Cancer Research UK, in 2018, around 17 million new cases of cancer were recorded with deaths of around 9.6 million, and the estimated cancer incidence rate is 62% between 2018-2040 worldwide. The rise in the global incidence of cancer has boosted the demand for the viral vectors and plasmid DNA market.

The unaffordable cost of gene therapies is a major challenge in the viral vectors & plasmid DNA market. The prices of gene therapies range between $0.2 million to $2.1 million. For instance, Gilead company`s Yescarta is a gene therapy that costs around $0.3 million and Bluebird Bio`s Letiglobin is another gene therapy costing around $2.1 million. The high price is due to various factors like government regulations, production costs, and so on. Therefore, the unaffordable cost of gene therapies is limiting the viral vector & plasmid DNA market growth.

In January 2020, Cognate Bioservices Inc, a US-based company skilled in cell and cell-mediated gene therapy products, acquired Cobra Biologics, specialized in providing manufacturing services for plasmid DNA and viral vector, for an undisclosed amount. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both the businesses to a better position to respond to current and future market demand.

Major players in the market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Kaneka Corporation, Cell and Gene Therapy Catapult, VGXI, MassBiologics.

The countries covered in the viral vectors & plasmid dna global market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

The viral vectors & plasmid dna global market report is segmented:
1) By Product: Plasmid DNA, Viral vectors
2) By Applications: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Others

    1. Executive Summary

    2. Viral Vectors & Plasmid DNA Market Characteristics

    3. Viral Vectors & Plasmid DNA Market Size And Growth

    3.1. Global Viral Vectors & Plasmid DNA Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Viral Vectors & Plasmid DNA Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Viral Vectors & Plasmid DNA Market Segmentation

    4.1. Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Plasmid DNA

    Viral vectors

    4.2. Global Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Gene And Cancer Therapies

    Viral Infections

    Immunotherapy

    Formulation Development

    Others

    5. Viral Vectors & Plasmid DNA Market Regional And Country Analysis

    5.1. Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Viral Vectors & Plasmid DNA Market

    6.1. Asia-Pacific Viral Vectors & Plasmid DNA Market Overview

    6.2. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Viral Vectors & Plasmid DNA Market

    7.1. China Viral Vectors & Plasmid DNA Market Overview

    7.2. China Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7.3. China Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8. India Viral Vectors & Plasmid DNA Market

    8.1. India Viral Vectors & Plasmid DNA Market Overview

    8.2. India Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Viral Vectors & Plasmid DNA Market

    9.1. Japan Viral Vectors & Plasmid DNA Market Overview

    9.2. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Viral Vectors & Plasmid DNA Market

    10.1. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Viral Vectors & Plasmid DNA Market

    11.1. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Viral Vectors & Plasmid DNA Market

    12.1. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Viral Vectors & Plasmid DNA Market

    13.1. Western Europe Viral Vectors & Plasmid DNA Market Overview

    13.2. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Viral Vectors & Plasmid DNA Market

    14.1. UK Viral Vectors & Plasmid DNA Market Overview

    14.2. UK Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Viral Vectors & Plasmid DNA Market

    15.1. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Viral Vectors & Plasmid DNA Market

    16.4. France Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.5. France Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Viral Vectors & Plasmid DNA Market

    17.1. Eastern Europe Viral Vectors & Plasmid DNA Market Overview

    17.2. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Viral Vectors & Plasmid DNA Market

    18.1. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Viral Vectors & Plasmid DNA Market

    19.1. North America Viral Vectors & Plasmid DNA Market Overview

    19.2. North America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Viral Vectors & Plasmid DNA Market

    20.1. USA Viral Vectors & Plasmid DNA Market Overview

    20.2. USA Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Viral Vectors & Plasmid DNA Market

    21.1. South America Viral Vectors & Plasmid DNA Market Overview

    21.2. South America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Viral Vectors & Plasmid DNA Market

    22.1. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Viral Vectors & Plasmid DNA Market

    23.1. Middle East Viral Vectors & Plasmid DNA Market Overview

    23.2. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Viral Vectors & Plasmid DNA Market

    24.1. Africa Viral Vectors & Plasmid DNA Market Overview

    24.2. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Viral Vectors & Plasmid DNA Market Competitive Landscape And Company Profiles

    25.1. Viral Vectors & Plasmid DNA Market Competitive Landscape

    25.2. Viral Vectors & Plasmid DNA Market Company Profiles

    25.2.1. FUJIFILM Diosynth Biotechnologies

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. FinVector Vision Therapies

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Lonza

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Cobra Biologics and Pharmaceutical Services

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Brammer Bio

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Viral Vectors & Plasmid DNA Market

    27. Viral Vectors & Plasmid DNA Market Trends And Strategies

    28. Viral Vectors & Plasmid DNA Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: China, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: China, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: India, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: India, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: France, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: France, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: FUJIFILM Diosynth Biotechnologies Financial Performance
  • Table 46: FinVector Vision Therapies Financial Performance
  • Table 47: Lonza Financial Performance
  • Table 48: Cobra Biologics and Pharmaceutical Services Financial Performance
  • Table 49: Brammer Bio Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: China, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: China, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: India, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: India, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: France, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: France, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: FUJIFILM Diosynth Biotechnologies Financial Performance
  • Figure 46: FinVector Vision Therapies Financial Performance
  • Figure 47: Lonza Financial Performance
  • Figure 48: Cobra Biologics and Pharmaceutical Services Financial Performance
  • Figure 49: Brammer Bio Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)